Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Federal Spending Bill Offers Re-Enrollment Path for Some Hospitals

By Michael French, Brenda Maloney Shafer & Richard Davis on March 22, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

UPDATED on 3/22/2022

In a move welcomed by the growing number of hospitals forced out of the 340B Program due to falling disproportionate share hospital (DSH) adjustment percentages, Congress has passed a measure offering a chance to rejoin. Tucked away in the 2022 Consolidated Appropriations Act signed into law March 15, 2022, the bill provides a temporary re-enrollment path for hospitals that lost their 340B eligibility during the COVID-19 pandemic due to falling below the minimum DSH threshold required by the 340B statute (11.75% for DSH, free-standing cancer (CAN), and children’s (PEDS) hospitals, 8% for sole community (SCH) and rural referral center (RRC) hospitals).

While the parameters of the relief are not yet fully defined, here’s what we know so far:

  • To qualify for temporary 340B Program re-enrollment, the hospital must:
    • Meet all 340B Program eligibility requirements other than the minimum DSH adjustment percentage threshold
    • Have been an active and registered 340B Covered Entity at least one day before the Public Health Emergency began
    • Have lost 340B eligibility due to its DSH adjustment percentage falling below the required threshold during a Medicare cost reporting period that began in 2020 or a subsequent year but that does not end after Dec. 31, 2022
  • Eligible hospitals must file “an attestation that contains information on any actions taken by or other impact on such hospital in response to or as a result of the COVID-19 public health emergency that may have impacted the ability to meet the applicable requirement for the disproportionate share adjustment percentage”
    • For hospitals that previously lost 340B eligibility during the pandemic, attestations must be filed within 30 days of the bill’s March 15, 2022 enactment date
    • For hospitals that lose their 340B eligibility after March 15, 2022, attestations must be filed within 30 days of the date eligibility was lost
  • The Health Resources and Services Administration (HRSA) has begun contacting Covered Entities terminated during the pandemic and providing them with a formal attestation form to complete. Covered Entities must, among other items, submit a narrative explaining how the Covered Entity’s COVID-19 response led to its DSH adjustment percentage dropping below minimum eligibility thresholds
  • If approved, HRSA will reinstate all registrations (including child sites and contract pharmacies) that were active at the time of the Covered Entity’s termination. 340B eligibility would extend through the hospital’s cost reporting period (but would extend no later than December 31, 2022). It is unclear at this stage if a hospital will have to file multiple attestations if its DSH adjustment percentage fell or will fall below the minimum threshold for multiple cost reporting periods in the defined timeframe
  • If approved, 340B eligibility would only begin on the date of the bill’s enactment and would not apply retroactively

Quarles & Brady will continue to update this post as more information and guidance is released.

If your hospital recently lost 340B eligibility and is interested in filing an attestation for re-enrollment, please contact your Quarles & Brady attorney or:

  • Michael French: (312) 715-5261 / michael.french@quarles.com
  • Brenda M. Maloney Shafer: (602) 229-5774 / brenda.shafer@quarles.com
  • Richard B. Davis: (414) 277-5844 / richard.davis@quarles.com
Photo of Michael French Michael French

Mike has unique experience in the 340B Program, utilizing his former 340B consulting background to blend legal analysis with operational and financial considerations. Mike has assisted an extensive list of 340B stakeholders optimize available 340B benefit while ensuring compliance with the 340B Program’s…

Mike has unique experience in the 340B Program, utilizing his former 340B consulting background to blend legal analysis with operational and financial considerations. Mike has assisted an extensive list of 340B stakeholders optimize available 340B benefit while ensuring compliance with the 340B Program’s complex regulatory structure.

Read more about Michael FrenchEmailMichael's Linkedin Profile
Show more Show less
Photo of Brenda Maloney Shafer Brenda Maloney Shafer

Brenda is a member of Quarles & Brady’s Health Law Practice Group. Her practice focuses primarily in health law and, in particular, health care regulatory and transactional work. Along with her law degree, she holds a Master’s of Law in Health Law. A…

Brenda is a member of Quarles & Brady’s Health Law Practice Group. Her practice focuses primarily in health law and, in particular, health care regulatory and transactional work. Along with her law degree, she holds a Master’s of Law in Health Law. A particular area of focus is counseling clients regarding compliance with the 340B Drug Pricing Program.

Read more about Brenda Maloney ShaferEmailBrenda Maloney's Linkedin Profile
Show more Show less
Photo of Richard Davis Richard Davis

Richie has extensive experience with the 340B Program and has worked with both contract pharmacies and covered entities to develop and optimize their program participation. His practice also focuses on a wide variety of pharmacy regulatory issues, including controlled substances and state licensure…

Richie has extensive experience with the 340B Program and has worked with both contract pharmacies and covered entities to develop and optimize their program participation. His practice also focuses on a wide variety of pharmacy regulatory issues, including controlled substances and state licensure compliance.

Read more about Richard DavisEmailRichard's Linkedin Profile
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    To Be or Not to 340B Blog
  • Organization:
    Quarles & Brady LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo